Any anti-TB regimen received in the past for one month or more, whether first- or second-line

Patients who have received 1 month or more of anti-TB medicines in the past. Previously treated cases may have been treated with a first-line regimen for drug-susceptible TB or a second-line regimen for drug-resistant forms (e.g. shorter MDR-TB regimen)

Newly registered episode of TB in a patient who, in response to direct questioning admits having been treated for TB for one month or more, or, in countries where adequate documentation is available, there is evidence of such history. Chemoprophylaxis should not be considered treatment for TB

Cases previously treated with an individualized regimen including fluoroquinolones or injectable agents in addition to first-line TB medicines

Patient who has received 1 month or more of anti-TB drugs in the past, may have positive or negative bacteriology and may have disease at any anatomical site. They are further classified by the outcome of their most recent course of treatment (relapse, failure or default)

Patients who have received 1 month or more of anti-TB drugs in the past. They are further classified by the outcome of their most recent course of treatment

Patient who has been treated for one month or more for TB with only first-line drugs

Treatment for 1 month or more with any drug in Drug Group 1